EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.

导出原文传递

翻译打印收藏纠错

作者： Anne,Caudron ^[1] ; Maxime,Battistella ^[2] ; Jean-Paul,Feugeas ^[3] ; Cécile,Pages ^[4] ; Nicole,Basset-Seguin ^[3] ; Sarra,Mazouz Dorval ^[5] ; Elisa,Funck Brentano ^[6] ; Aurélie,Sadoux ^[7] ; Marie-Pierre,Podgorniak ^[3] ; Suzanne,Menashi ^[7] ; Anne,Janin ^[8] ; Céleste,Lebbé ^[9] ; Samia,Mourah ^[10]

作者单位： Inserm U 976, Paris, France. ^[1] Inserm U 1165, Paris, France. ^[2] Sorbonne Paris Cité, Université Paris Diderot, Paris, France. ^[3] Department of Pathology, AP-HP, Hôpital Saint-Louis, Paris, France. ^[4] INSERM, IAME, UMR 1137, Paris, France. ^[5] Department of Biochemistry, AP-HP, Hôpital Saint-Louis, Paris, France. ^[6] Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. ^[7] Department of plastic surgery, AP-HP, Hôpital Saint-Louis, Paris, France. ^[8] EA4340, Versailles University, Boulogne-Billancourt, France. ^[9] AP-HP, Ambroise Paré Hospital, Department of Dermatology, Boulogne-Billancourt, France. ^[10] AP-HP, Laboratoire de Pharmacologie Biologique, Hôpital Saint-Louis, Paris, France. ^[11] Laboratoire CRRET, CNRS-UMR 7149, Créteil, France. ^[12] Université Paris 12, Créteil, France. ^[13]

关键词 disease-free survival invasion melanoma progression metastasis overall survival